New Haven Pharmaceuticals Lands $6,490,773 New Funding
- Feed Type
- Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=94c34e1b-d328-41b8-b695-74d887e572db&Preview=1 - Date
10/4/2012 - Company Name
New Haven Pharmaceuticals - Mailing Address
142 Temple Street New Haven, CT 06510 - Company Description
New Haven Pharmaceuticals, Inc. (NHP) develops proprietary, controlled release specialty pharmaceuticals based on approved or GRAS active pharmaceutical ingredients for use in new therapeutic indications. NHP’s novel product pipeline is built on three licenses from Yale University and Micropump Aspirin, the world’s only 24-hour controlled-release aspirin, licensed from Flamel Technologies. - Website
http://www.newhavenpharma.com - Transaction Type
Venture Equity - Transaction Amount
$6,490,773 - Transaction Round
Undisclosed - Proceeds Purposes
Proceeds purposes were not disclosed. SEC regulatory filing. - M&A Terms
- Venture Investor
Undisclosed
